Study to Evaluate the Safety and Tolerability of CC-94676 in Participants With Metastatic Castration-Resistant Prostate Cancer

Clinical trial NCT04428788 · COMPLETED

Trial details

NCT number: NCT04428788
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prostatic Neoplasms

Start date: 2020-06-22
Primary completion: 2025-10-28
Enrollment: 131

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.